Aon's Q3 Adjusted Earnings, Revenue Rise-February 2024-www.financetom.com

Aon's Q3 Adjusted Earnings, Revenue Rise

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Aon's Q3 Adjusted Earnings, Revenue Rise

Nov 3, 2024 11:24 AM

06:20 AM EDT, 10/25/2024 (MT Newswires) -- Aon (AON) reported Q3 adjusted earnings Friday of $2.72 per diluted share, up from $2.32 a year earlier.

Analysts surveyed by Capital IQ expected $2.47.

Total revenue for the quarter ended Sept. 30 was $3.72 billion, up from $2.95 billion a year earlier.

Analysts surveyed by Capital IQ expected $3.69 billion.

Price: 360.00, Change: +3.15, Percent Change: +0.88

Previous page： Rubrik Insider Sold Shares Worth $304,382, According to a Recent SEC Filing Next page： KKR Buys Portfolio of Four Industrial Warehouses in Florida

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Rubrik Insider Sold Shares Worth $304,382, According to a Recent SEC Filing

Oct 22, 2024

05:32 PM EDT, 10/21/2024 (MT Newswires) -- Kiran Kumar Choudary, Chief Financial Officer, on October 17, 2024, sold 7,583 shares in Rubrik ( RBRK ) for $304,382. Following the Form 4 filing with the SEC, Choudary has control over a total of 438,560 shares of the company, with 438,560 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1943896/000141588924025463/xslF345X05/form4-10212024_091009.xml ...

KKR Buys Portfolio of Four Industrial Warehouses in Florida

Oct 22, 2024

05:37 PM EDT, 10/21/2024 (MT Newswires) -- KKR (KKR) said Monday it purchased a portfolio of four class A industrial warehouses in Central Florida. The properties, encompassing around 1.2 million square feet, are situated at the junction of Interstate 4 and U.S. Route 27 in southwest Orlando. The assets are fully leased to five tenants, according to the company. KKR...

Revolution Medicines Doses First Patient in Phase 3 Study of Pancreatic Cancer Drug

Oct 22, 2024

05:36 PM EDT, 10/21/2024 (MT Newswires) -- Revolution Medicines ( RVMD ) dosed the first patient in its phase 3 study evaluating RMC-6236 as a potential treatment for previously treated, metastatic pancreatic ductal adenocarcinoma. The open-label study will evaluate the safety and efficacy of RMC-6236 as a monotherapy against standard of care chemotherapy, Revolution Medicines ( RVMD ) said Monday...

Nucor Stock Falls After Q3 Results, Weak Q4 EPS Guidance: Details

Oct 22, 2024

Nucor Corp ( NUE ) shares are trading lower after the company reported its third-quarter financial results and announced it expects its fourth-quarter earnings to decline to $1.05. Here's a look at the details from the report. The Details: Nucor ( NUE ) reported quarterly earnings of $1.49 per share, which beat the analyst consensus estimate of $1.47. Quarterly revenue...